Humanigen Inc (fka HGENQ)

[cowtown jay]

$100B. I said that in May and I think I'll stay with that.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163601096

If we only end up generating tens of billions of dollars in revenue, and if it takes a little more than a year, I can live with that, just as millions of patients suffering from various indications, and facing self-destruction from cytokine storm, will also be able to live with that. Thank God.

That's 10M treatments, so we MUST have substantial (to us) national stockpile orders. We may need full US government OWS-type assistance, or a Big Pharma partner, in order to procure the resources needed to meet that production. But it's doable, if the demand is there.

We have a feel for pending demand, in addition to Covid. But aside from the opportunities as reflected in our pipeline, I think we could be pleasantly surprised by fulfilling a role as an Antibody Drug Conjugate (ADC). Durrant said this was worth $20B to a competitor, and that the FDA is receptive to ADC's.

https://www.businesswire.com/news/home/20211126005524/en/

I think we need to augment the number of patients that we have treated, in order to present safety and efficacy data that currently doesn't reassure the FDA, despite p values as low as 0.0009 - 0.0003 on some of our results. So I really hope that LenzMAP and our own international promotion generates more than enough confirmatory data. That really shouldn't even be required, especially when there is data being generated in the NIH-sponsored trial, as well. Just as there is data from lenz trials being sponsored by various Humanigen partners.

But we're not a Big Pharma, yet.